Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
New Drugs
100%
Resistant Cancer Cells
100%
Doxorubicin
50%
P-glycoprotein (P-gp)
37%
MCF-7
25%
Multidrug Resistance
25%
Clinical Trials
12%
Enhanced Activity
12%
Human Breast Cancer Cells
12%
IC50
12%
Mechanism of Action
12%
Drug Efflux
12%
Efflux
12%
Structural Requirements
12%
Multidrug Resistance Phenotype
12%
Rhodamine 123
12%
Multidrug Resistance Reversal
12%
Low Toxicity
12%
Leukemia Cells
12%
Effective Compounds
12%
Murine Leukemia
12%
Toxicity Profile
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Terfenadine
100%
Multiple Drug Resistance
55%
Doxorubicin
44%
P-Glycoprotein
33%
Effusion
22%
Breast Cancer
11%
Clinical Trial
11%
IC50
11%
Rhodamine 123
11%
Murine Leukemia
11%
Azidopine
11%
Flupentixol
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Terfenadine
100%
Multidrug Resistance
62%
Doxorubicin
50%
P-Glycoprotein
37%
IC50
12%
Clinical Trial
12%
Flupentixol
12%
Rhodamine 123
12%
Drug Accumulation
12%
Immunology and Microbiology
Cancer Cell
100%
Terfenadine
100%
Multidrug Resistance
55%
P-Glycoprotein
33%
Cell Line
11%
IC50
11%
Leukemia Cell
11%
Drug Accumulation
11%